Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1A

被引:6
|
作者
Miyazaki, Yuka [1 ]
Kikuchi, Masaki [2 ]
Umezawa, Koji [3 ]
Descamps, Aurelie [4 ]
Nakamura, Daichi [4 ]
Furuie, Gaku [1 ]
Sumida, Tomoe [4 ,6 ]
Saito, Kanako [1 ]
Kimura, Ninako [1 ]
Niwa, Takashi [4 ]
Sumida, Yuto [4 ,6 ]
Umehara, Takashi [2 ]
Hosoya, Takamitsu [4 ,5 ]
Kii, Isao [1 ,3 ,4 ]
机构
[1] Shinshu Univ, Grad Sch Sci & Technol, Dept Agr, Lab Drug Target Res, 8304 Minami Minowa, Nagano 3994598, Japan
[2] RIKEN, Lab Epigenet Drug Discovery, Ctr Biosyst Dynam Res, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan
[3] Shinshu Univ, Inst Biomed Sci, Dept Biomol Innovat, 8304 Minami Minowa, Nagano 3994598, Japan
[4] RIKEN, Lab Chem Biol, Ctr Biosyst Dynam Res, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[5] Tokyo Med & Dent Univ TMDU, Inst Biomat & Bioengn, Lab Chem Biosci, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo, Japan
[6] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan
关键词
DYRK1A; Folding intermediate; Autophosphorylation; FINDY; Alzheimer's disease; Down syndrome; DOWN-SYNDROME CANDIDATE; PROTEIN-KINASE; MOUSE MODEL; MURINE MODEL; DRUG-TARGET; CYCLIN D1; ACTIVATION; AUTOPHOSPHORYLATION; OVEREXPRESSION; REVEALS;
D O I
10.1016/j.ejmech.2021.113948
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DYRK1A phosphorylates proteins involved in neurological disorders in an intermolecular manner. Meanwhile, during the protein folding process of DYRK1A, a transitional folding intermediate catalyzes the intramolecular autophosphorylation required for the "one-off" inceptive activation and stabilization. In our previous study, a small molecule termed FINDY (1) was identified, which inhibits the folding intermediate-catalyzed intramolecular autophosphorylation of DYRK1A but not the folded state-catalyzed intermolecular phosphorylation. However, the structural features of FINDY (1) responsible for this intermediate-selective inhibition remain elusive. In this study, structural derivatives of FINDY (1) were designed and synthesized according to its predicted binding mode in the ATP pocket of DYRK1A. Quantitative structure-activity relationship (QSAR) of the derivatives revealed that the selectivity against the folding intermediate is determined by steric hindrance between the bulky hydrophobic moiety of the derivatives and the entrance to the pocket. In addition, a potent derivative 3 was identified, which inhibited the folding intermediate more strongly than FINDY (1); it was designated as dp-FINDY. Although dp-FINDY (3) did not inhibit the folded state, as well as FINDY (1), it inhibited the intramolecular autophosphorylation of DYRK1A in an in vitro cell-free protein synthesis assay. Furthermore, dp-FINDY (3) destabilized endogenous DYRK1A in HEK293 cells. This study provides structural insights into the folding intermediate-selective inhibition of DYRK1A and expands the chemical options for the design of a kinase inhibitor. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model
    Kurabayashi, Nobuhiro
    Nguyen, Minh Dang
    Sanada, Kamon
    EMBO REPORTS, 2015, 16 (11) : 1548 - 1562
  • [22] Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
    Walmsley, David Lee
    Murray, James B.
    Dokurno, Pawel
    Massey, Andrew J.
    Benwell, Karen
    Fiumana, Andrea
    Foloppe, Nicolas
    Ray, Stuart
    Smith, Julia
    Surgenor, Allan E.
    Edmonds, Thomas
    Demarles, Didier
    Burbridge, Mike
    Cruzalegui, Francisco
    Kotschy, Andras
    Hubbard, Roderick E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 8971 - 8991
  • [23] DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
    Wang, Pin
    Zhao, Juan
    Sun, Xiulian
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (13) : 6082 - 6093
  • [24] Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis
    Lee, Youngkyun
    Ha, Jeongim
    Kim, Hyung Joon
    Kim, Yeun-Soo
    Chang, Eun-Ju
    Song, Woo-Joo
    Kim, Hong-Hee
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (48) : 33343 - 33351
  • [25] Regulation of Dyrk1A kinase activity by 14-3-3
    Kim, D
    Won, J
    Shin, DW
    Kang, J
    Kim, YJ
    Choi, SY
    Hwang, MK
    Jeong, BW
    Kim, GS
    Joe, CO
    Chung, SH
    Song, WJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 323 (02) : 499 - 504
  • [26] Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors
    Rueben, Katharina
    Wurzlbauer, Anne
    Walte, Agnes
    Sippl, Wolfgang
    Bracher, Franz
    Becker, Walter
    PLOS ONE, 2015, 10 (07):
  • [27] Multi-step virtual screening to develop selective DYRK1A inhibitors
    Koyama, Tomoko
    Yamaotsu, Noriyuki
    Nakagome, Izumi
    Ozawa, Shin-ichiro
    Yoshida, Tomoki
    Hayakawa, Daichi
    Hirono, Shuichi
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2017, 72 : 229 - 239
  • [28] Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors
    Tahtouh, Tania
    Durieu, Emilie
    Villiers, Benoit
    Bruyere, Celine
    Thu Lan Nguyen
    Fant, Xavier
    Ahn, Kwang H.
    Khurana, Leepakshi
    Deau, Emmanuel
    Lindberg, Mattias F.
    Severe, Elodie
    Miege, Frederic
    Roche, Didier
    Limanton, Emmanuelle
    L'helgoual'ch, Jean-Martial
    Burgy, Guillaume
    Guiheneuf, Solene
    Herault, Yann
    Kendall, Debra A.
    Carreaux, Francois
    Bazureau, Jean-Pierre
    Meijer, Laurent
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (02) : 1396 - 1417
  • [29] The Inhibition of DYRK1A Improves Parkinson's Disease by Inhibiting the Phosphorylation of α-Synuclein and Apoptosis of Dopaminergic Neurons
    Yong, Yuxuan
    Wu, Qinfen
    Meng, Xinling
    Lu, Ranran
    Xia, Huan
    Pei, Feifei
    Yang, Xinling
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (08) : 4323 - 4333
  • [30] STRUCTURE-ACTIVITY RELATIONSHIP OF PHENYLETHANOID GLYCOSIDES ON THE INHIBITION OF AMYLOID β AGGREGATION
    Kidachi, Eri
    Kurisu, Manami
    Miyamae, Yusaku
    Hanaki, Mizuho
    Murakami, Kazuma
    Irie, Kazuhiro
    Shigemori, Hideyuki
    HETEROCYCLES, 2016, 92 (11) : 1976 - 1982